Flow’s headset is the first tDCS device approved by the FDA ...

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

The FDA has approved the first at -home brain-stimulation device for adults with major depressive disorder (MDD). The FL-100 transcranial direct-current stimulation (tDCS) system (Flow Neuroscience) ...

Research investigating the effects of transcranial direct current stimulation (tDCS) on individuals with depression and ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...

A headset that stimulates the brain with electricity is able to relieve symptoms of major depression in 57.5% of patients, a new trial has found. Researchers at Kings College London studied 174 ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

For the first time, Americans with depression will soon be able to use a prescription brain-stimulation device at home. The approval comes from the U.S. Food and Drug Administration and marks a major ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...